Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13503)

• Formulation Name: Methsuximide 300 mg capsule
• Company: Parke-Davis Div of Pfizer Inc

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methsuximide	(DM6L5VO)	Epileptic seizures	8A61-8A6Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant